What Analyst Projections for Key Metrics Reveal About Merit Medical (MMSI) Q1 Earnings

Core Viewpoint - Wall Street analysts anticipate a slight decline in Merit Medical's quarterly earnings per share, while revenues are expected to show growth compared to the previous year [1]. Earnings Estimates - Analysts expect Merit Medical (MMSI) to report earnings of $0.75 per share, reflecting a year-over-year decline of 2.6% [1]. - Revenue is projected to be $352.33 million, indicating an increase of 8.9% from the same quarter last year [1]. - The consensus EPS estimate has been revised down by 0.1% in the last 30 days, indicating a reassessment by covering analysts [1][2]. Revenue Projections - Revenue from 'Cardiovascular- Peripheral Intervention' is estimated to reach $141.95 million, a year-over-year increase of 5.4% [4]. - 'Cardiovascular- Cardiac Intervention' revenue is expected to be $98.79 million, reflecting an 8.9% increase year over year [4]. - 'Endoscopy' revenue is projected at $17.89 million, showing a significant year-over-year increase of 76.5% [5]. - 'Cardiovascular- OEM' revenue is expected to be $43.84 million, indicating an 11.6% increase from the previous year [5]. - Total 'Cardiovascular' revenue is projected to reach $334.45 million, reflecting a 6.7% year-over-year change [5]. Geographic Sales Estimates - 'Geographic Sales- United States' is estimated at $208.66 million, suggesting a year-over-year increase of 12.1% [6]. - 'Geographic Sales- International' is projected to be $143.33 million, indicating a 4.3% increase year over year [6]. Stock Performance - Over the past month, Merit Medical shares have decreased by 10.6%, compared to a 5.6% decline in the Zacks S&P 500 composite [7]. - Currently, MMSI holds a Zacks Rank 3 (Hold), suggesting its performance may align with the overall market in the near future [7].